BWC-5044

N/A

Report date: 2026/01/14 17:56:30
NME

Base Information

Drug NameBWC-5044
Drug Alias NameBWC5044BWC-5044
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 7 inhibitors
TargetsCyclin-dependent kinase 7
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBugworks Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesBugworks Research Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A